News

Unilever’s ‘Take Pride in Your Pregame’ college football program hits retail

BY Antoinette Alexander

ENGLEWOOD CLIFFS, N.J. — Unilever revealed this month the new "Take Pride in Your Pregame" program featuring ESPN college football analyst and SEC Network host Jesse Palmer to help guys take pride in their everyday grooming routines.
 
The new campaign includes pop-up displays in retailers nationwide and features products across the entire Unilever men's personal care portfolio. By creating a one-stop shopping experience where men can find all of their grooming product needs in one place, the partnership is yet another example of how Unilever is striving to revolutionize the way men shop. The displays are designed to help educate and encourage men to develop and maintain grooming habits and will be in stores throughout college football season.

"We know that men are becoming more sophisticated when it comes to grooming, and look for products that tailor to their specific needs," said Matthew McCarthy, senior director of men's grooming for Unilever. "This program gives men a variety of options to choose from all in one place, and there is no better person to lead the program than Jesse Palmer, who knows about pregame grooming rituals as a player and broadcaster."

Launching in stores nationwide in September, the Take Pride in Your Pregame program offers men grooming options from across the Unilever men's personal care portfolio, including Axe body spray, Dove Men+Care face wash, Degree deodorant sticks, Suave Men shower gel, Clear shampoo and Vaseline skin lotion.  

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Rx.com Community Healthcare Network launches clinical services documentation platform to track MTM, CMR

BY Michael Johnsen

FORT WORTH, Texas — Rx.com Community Healthcare Network on Friday announced the release of the Care Rx application — a streamlined, patient-centric approach to clinical outcomes. Care Rx serves as a complete clinical services documentation platform for patient-focused medication therapy management, clinical disease management results and wellness programs. 
 
“The best feature of Care Rx is its flexibility. You can use your own custom MTM program if a local health plan requires it for network access or you can use one supplied by PDX,” said PDX CEO Jeff Farris. “Also, gaining momentum in the market is the push to provide accessible healthcare professionals that can offer patient services in convenient locations. We believe Care Rx equips pharmacists with a flexible clinical services platform necessary to remain competitive in this outcomes-based environment.”
 
With the Care Rx application, pharmacies are now able to collect data, perform MTM sessions, track medication adherence, perform Comprehensive Medication Reviews, execute high-touch specialty drug clinical programs, enter lab results, record activities such as vaccinations, and give pharmacists the opportunity to collaborate with patients in wellness programs. Care Rx also provides Rx.com Performance Network participants the opportunity to perform Manufacturer-provided MTM questions, modules and sessions that focus on the patient, drug and disease. 
 
Care Rx is integrated with PDX’s Enterprise Pharmacy System, the Community Pharmacy System and the PDX Classic system and is available via a secure sign-on from any web browser. When the Care Rx application is enabled within one of the compatible systems, pharmacists log in via the Patient Information page in which patient identification and triggers can be established to identify MTM opportunities. 
 
Integrated with the Rx.com Electronic Pharmacy Record, Care Rx facilitates the real-time aggregation of clinical data into a patient’s EHR. Data collected through MTM sessions — including any standardized records as well as lab results — become part of the patient’s clinical view. This data—along with prescription data—provides a comprehensive view of a patient’s overall health care status.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Mylan, Gilead partner to expand access to hepatitis C treatments

BY Ryan Chavis

PITTSBURGH and HYDERABAD, India — Mylan announced that its subsidiary, Mylan Labs Limited, has signed an agreement with Gilead Science under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single-tablet regimen of ledipasvir/sofosbuvir in 91 developing countries. Sofosbuvir is marketed by Gilead under the name Sovaldi. 
 
The countries that fall within the terms of the agreement account for more than 100 million people living with hepatitis C. Mylan will receive a technology transfer allowing it to manufacture low-cost versions of the medicines, the company stated. 
 
"Hepatitis C is a growing public health problem in developing countries, with Central and East Asia and North Africa among the regions most affected by this disease," Mylan CEO Heather Bresch said. "Unfortunately, patients in these regions often lack access to critical and effective treatments. This agreement with Gilead will allow Mylan to provide early access to a more affordable version of Sovaldi, helping to meet the unmet medical needs of the millions of patients in developing countries who do not currently have access to this life-saving medicine."
 
Sofosbuvir was approved by the Food and Drug Administration in December 2013. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?